Foundation Medicine, Inc. recalls FoundationOne Companion Diagnostic (F1CDx)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.
- Products
-
- FoundationOne Companion Diagnostic (F1CDx)
- Company
- Foundation Medicine, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.
States: Georgia, New York
- Units affected
- 4 units
- About this recall
- FoundationOne Companion Diagnostic (F1CDx)